EZH2 and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, the polycomb group of proteins, consisting of polycomb repressive complex 1 and 2 (PRC1/2), have been identified as crucial modulators of CML pathogenesis by mediating the methylation of histone H3, initiated by the catalytic subunit of PRC2, EZH2.